Andrew G. Long is the Executive Vice President and Chief Executive Officer of Products & Healthcare Services at Accendra Health Inc., where he oversees the strategic direction, product innovation, and delivery of comprehensive healthcare solutions for millions of patients worldwide. With more than 25 years of leadership in the healthcare and life sciences sectors, Andrew has built a distinguished career transforming complex organizations into high-performing entities focused on patient outcomes, operational excellence, and sustainable growth. Prior to Accendra, Andrew served as President of Global Healthcare Solutions at MediTech Innovations, where he led the development and launch of AI-driven diagnostic platforms that captured 35% market share and generated over $750 million in revenue within three years. His earlier roles included executive positions at Johnson & Johnson and Pfizer, where he spearheaded cross-functional teams to commercialize blockbuster therapies, earning him the Healthcare Businesswomen's Association Rising Star Award and multiple patents in personalized medicine technologies. Andrew's expertise in regulatory navigation, supply chain optimization, and digital health integration has consistently delivered double-digit growth and cost savings exceeding 20%. At Accendra Health, Andrew drives the integration of cutting-edge products with value-based healthcare services, emphasizing data analytics and telemedicine to enhance accessibility and efficacy. Under his guidance, the division has accelerated pipeline advancements, forged key partnerships with major health systems, and positioned Accendra as a pioneer in precision healthcare, poised for exponential expansion in emerging markets.